The takeaway
Procter & Gamble Company shows a moderate seasonal pattern over 10 years of data — strongest in November (+2.6%) and softest in February (−2.1%).
Right now
In July, the stock has risen 70% of years, averaging +2.6% — essentially in line with the S&P 500.
The full picture
Procter & Gamble Company's most dependable month has been November, higher in 8 of 10 years; February has been its least reliable, up just 30% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | ||||||||||||
| 2021 | ||||||||||||
| 2020 | ||||||||||||
| 2019 | ||||||||||||
| 2018 | ||||||||||||
| 2017 | ||||||||||||
| 2016 |
Month by month
The stock's clearest edge over the S&P 500 lands in June (+1.5 pts); it has trailed the market most in February (−1.9 pts).
“vs S&P” is Procter & Gamble Company’s average for a month minus the S&P 500’s average for that same month — isolating Procter & Gamble Company’s own seasonal edge from broad market drift.
Reality check
Over the last 5 years, November has closed higher 100% of the time versus 80% across the last 10 years — the pattern is strengthening.
Figures are the typical (median) November return and how often it rose — the last 5 years versus the last 10(the heatmap’s default window). This verdict stays anchored to that 10-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
Dependability is the through-line here. November stands out, higher in 8 of 10 Novembers, but it heads a clutch of months that pull the year reliably upward.
Its average (+2.6%) and median (+2.0%) land within a hair of each other — the tell of steady, year-after-year gains rather than one outlier doing the work. Set against the S&P 500, mind, November is close to a wash — the gain mirrors the market more than it beats it. That consistency sets it apart from the field, where the average stock manages November only about 62% of the time.
A few other months pull their weight: January, March, and June have also closed higher more often than not. On the other side of the ledger, February has been the soft spot — the weakest of 3 months that average a loss (−2.1%), and the edge isn't year-round — the stock has trailed the S&P 500 in February, September, and May.
November has now closed higher 6 years running. If anything it has sharpened recently — the last five Novembers run ahead of the earlier years.
The takeaway is less about when to buy than what to expect: November aside, the stock's months offer little reliable tilt.
Short answers on the stock's best month (November), its worst (February), and whether it really trades seasonally.
Yes, to a moderate degree. Since 2016 its best month (November, +2.6%) has run well ahead of its worst (February, −2.1%) — the heatmap above shows how steady that gap has been year to year.
November has been the strongest, averaging +2.6% and closing higher in 8 of 10 years since 2016.
It's the weakest, averaging −2.1% — historically a soft spot, though it still varies from year to year.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade